Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spinal muscular atrophy treatment via targeting SMN2 catalytic core

Spinal muscular atrophy treatment via targeting SMN2 catalytic core

US Patent 9217147 · Granted Dec 22, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Link loss detection2025
Low-density parity check decoding2020
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2019
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2019
Participation factor based method for resynchronization of microgrids2018
Deep intronic target for splicing correction on spinal muscular atrophy gene2018
Deep intronic target for splicing correction on spinal muscular atrophy gene2018
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2016
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2016
Spinal muscular atrophy treatment via targeting SMN2 catalytic core2014
Spinal muscular atrophy treatment via targeting SMN2 catalytic core2014
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibi2013